Akebia Therapeutics Inc (NASDAQ:AKBA)

0.3866
Delayed Data
As of Aug 09
 -0.0184 / -4.54%
Today’s Change
0.30
Today|||52-Week Range
3.35
-82.89%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-60.7M-135.7M-76.9M-143.6M
 
 
 
 
 
Depreciation96.0K296.0K617.0K2.4M
 
 
 
 
 
Total Other Cash Flow5.3M6.6M12.9M36.0M
 
 
 
 
 
Funds From Operations-55.3M-128.8M-63.4M-133.5M
 
 
 
 
 
Funds From/For Other Operating Expenses-2.9M-186.7M-7.2M-36.0M
 
 
 
 
 
Net Cash Flow - Operating Activities-52.4M57.9M-56.2M-97.5M
 
 
 
 
 
 
InvestingIncrease In Investments-77.2M-147.0M-330.6M-224.2M
 
 
 
 
 
Decrease In Investments63.9M162.4M155.0M256.3M
 
 
 
 
 
Capital Expenditures-414.0K-2.7M-1.6M-1.6M
 
 
 
 
 
Fixed Asset Disposal------6.1M
 
 
Net Cash Flow Investing-13.7M12.7M-177.3M36.6M
 
 
 
 
 
 
FinancingShort Term Borrowings----0.000.00--
Long Term Borrowings0.00--0.000.00--
Long Term Debt Reduction-7.0K-20.0K-5.0K-19.0K
 
 
 
 
 
Net Proceeds Stock Sale83.1M67.0M116.2M96.6M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.00--0.000.00--
Cash Dividends Paid - Total0.00--0.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing83.1M66.9M116.2M96.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash17.0M137.6M-117.2M35.7M